Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioReal is a Swedish biotechnology company specializing in the production of natural astaxanthin, a powerful antioxidant derived from the microalgae Haematococcus pluvialis. As a subsidiary of Fuji Chemical Industries, the company operates one of the world's first and largest indoor photobioreactor facilities for algae cultivation. BioReal's primary product, marketed under the brand name AstaReal, is utilized globally in the nutraceutical, functional food, and cosmetic industries. The company's business model focuses on the large-scale cultivation, extraction, and supply of high-purity astaxanthin supported by extensive clinical research into its benefits for human health, including muscle recovery, cardiovascular support, and skin health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioReal.